Quantum-Si incorporated (QSI)
After hours:
| Previous close | 1.6800 |
| Open | 1.7100 |
| Bid | 1.6000 x 300 |
| Ask | 1.6600 x 200 |
| Day's range | 1.6100 - 1.7100 |
| 52-week range | 1.1200 - 3.9010 |
| Volume | |
| Avg. volume | 758,545 |
| Market cap | 228.25M |
| Beta (5Y monthly) | 3.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6800 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.75 |
Business WireQuantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time
BRANFORD, Conn., April 30, 2024--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced upgrades to its Platinum® Analysis Software to reduce processing time and increase output and precision of Next-Generation Protein Sequencing™ (NGPS) data from the Platinum® instrument.
Business WireQuantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
BRANFORD, Conn., April 18, 2024--Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
Business WireQuantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors
BRANFORD, Conn., March 21, 2024--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors.
